Consider SGLT2 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
Approximately two-thirds of deaths related to type 2 diabetes are attributable to cardiovascular disease (CVD). Interventions to reduce cardiovascular risks in patients...
Personalized Care for Depression Improves Outcomes
Major depressive disorder is the greatest cause of workplace
disability, and depressive disorders are the world’s second greatest public
health issue. During a presentation...
Managed Care Considerations for the Management of Rheumatoid Arthritis
Rheumatoid arthritis (RA) affects about 1.3 million
Americans and, in 2010, was associated with $39 billion in medical costs.
Choosing a treatment option can...
Inclusion of Patients in Treatment Decision-Making Improves Adherence in Multiple Sclerosis
Multiple sclerosis (MS) is a lifelong, complex,
heterogenous, neurodegenerative disease with more than 20 disease-modifying
therapeutic treatment options. During a presentation at NAMCP 2020...
A Closer Look at Targeted Therapies for Advanced Breast Cancer
Individualized treatment for breast cancer has improved
clinical and economic outcomes. During a presentation at NAMCP 2020 Virtual
Spring Managed Care Forum, Hatem Soliman,...